Evaxion A/S Sustainability Reports
Evaxion A/S is a clinical-stage biotech company that develops artificial intelligence-powered immunology platforms to discover and develop novel immunotherapy treatments and vaccines.
Sector: Professional & technical services
Country: Denmark
Exchange: Nasdaq
FIGI: BBG00YTSS7Z8
2 reports from 2023 to 2025
Company Profile
Evaxion A/S is a clinical-stage biotech company that develops artificial intelligence-powered immunology platforms to discover and develop novel immunotherapy treatments and vaccines.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
